Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -6,15k | 666,98k | Automatic Disposition | 108,47 | 41,61k | -12,87% |
| 2026-05-18 | Mr. William H. LewisPresident, CEO & Chairman | -14,87k | 1,59M | Automatic Disposition | 106,39 - 106,97 | 506,96k | -2,85% |
| 2026-05-18 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 865,27k | Derivative Exercise and Sale | 17,16 - 106,39 | 506,96k | - |
| 2026-05-13 | Ms. Sara M. BonsteinCFO | -8,27k | 961,04k | Verkauf | 116,18 | 24,01k | -25,62% |
| 2026-05-13 | Mr. Roger AdsettCOO | -5,84k | 678,14k | Verkauf | 116,18 | 59,96k | -8,87% |
| 2026-05-14 | Dr. Martina FlammerChief Medical Officer | -10,48k | 1,23M | Automatic Disposition | 117,54 | 64,91k | -13,90% |
| 2026-05-13 | Dr. Martina FlammerChief Medical Officer | -7,85k | 897,19k | Verkauf | 112,76 - 116,18 | 64,91k | -10,79% |
| 2026-05-13 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -4,11k | 477,38k | Verkauf | 116,18 | 47,76k | -7,92% |
| 2026-05-13 | Mr. William H. LewisPresident, CEO & Chairman | -13,28k | 1,54M | Verkauf | 116,18 | 521,83k | -2,48% |
| 2026-05-11 | Dr. Martina FlammerChief Medical Officer | -12,95k | 1,08M | Derivative Exercise and Sale | 17,07 - 101,18 | 32,96k | - |
| 2026-05-04 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,20M | Derivative Exercise and Sale | 17,16 - 139,60 | 359,48k | - |
| 2026-04-16 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,27M | Derivative Exercise and Sale | 17,16 - 145,79 | 359,48k | - |
| 2026-04-06 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,48M | Derivative Exercise and Sale | 17,16 - 164,01 | 359,48k | - |
| 2026-04-01 | Mr. Roger AdsettCOO | -88,06k | 13,22M | Derivative Exercise and Sale | 14,56 - 164,95 | 47,39k | - |
| 2026-03-30 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -19,64k | 2,48M | Derivative Exercise and Sale | 17,07 - 150,98 | 51,87k | - |
| 2026-03-19 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,27M | Derivative Exercise and Sale | 17,16 - 144,11 | 359,48k | - |
| 2026-03-05 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,30M | Derivative Exercise and Sale | 17,16 - 147,54 | 359,48k | - |
| 2026-03-03 | Dr. Melvin SharokyIndependent Director | -100,00 | 0,00 | Other Disposition | - | 264,54k | -0,04% |
| 2026-02-25 | Dr. Melvin SharokyIndependent Director | -1,07k | 0,00 | Other Disposition | - | 264,64k | -0,40% |
| 2026-02-24 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -20,25k | 2,81M | Derivative Exercise and Sale | 17,07 - 156,53 | 51,87k | - |
| 2026-02-24 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -4,53k | 708,45k | Automatic Disposition | 156,53 | 51,87k | -8,03% |
| 2026-02-23 | Mr. David R. BrennanLead Independent Director | -6,00k | 0,00 | Other Disposition | - | 115,88k | -4,92% |
| 2026-02-19 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,35M | Derivative Exercise and Sale | 17,16 - 153,38 | 409,98k | - |
| 2026-02-09 | Mr. David W. J. McGirrInsider | -53,40k | 0,00 | Other Disposition | - | 92,67k | -36,56% |
| 2026-02-09 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,31M | Derivative Exercise and Sale | 17,16 - 148,02 | 409,98k | - |
| 2026-02-09 | Mr. William H. LewisPresident, CEO & Chairman | -2,70k | 400,25k | Automatic Disposition | 148,02 - 148,83 | 409,98k | -0,65% |
| 2026-02-05 | Dr. Martina FlammerChief Medical Officer | -869,00 | 132,47k | Automatic Disposition | 152,44 | 14,63k | -5,61% |
| 2026-02-03 | Mr. Roger AdsettCOO | -791,00 | 123,53k | Verkauf | 156,17 | 47,39k | -1,64% |
| 2026-02-03 | Ms. Sara M. BonsteinCFO | -748,00 | 116,94k | Verkauf | 156,34 | 8,01k | -8,54% |
| 2026-02-03 | Mr. William H. LewisPresident, CEO & Chairman | -3,01k | 470,43k | Verkauf | 156,34 | 412,68k | -0,72% |
| 2026-02-03 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -640,00 | 100,01k | Verkauf | 156,27 | 56,40k | -1,12% |
| 2026-02-02 | Dr. Martina FlammerChief Medical Officer | -7,98k | 709,38k | Derivative Exercise and Sale | 65,72 - 156,86 | 15,50k | - |
| 2026-02-03 | Dr. Martina FlammerChief Medical Officer | -795,00 | 123,84k | Verkauf | 155,77 | 15,50k | -4,88% |
| 2026-01-20 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,43M | Derivative Exercise and Sale | 17,16 - 160,70 | 409,98k | - |
| 2026-01-12 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,53M | Derivative Exercise and Sale | 17,16 - 168,63 | 415,69k | - |
| 2026-01-12 | Mr. William H. LewisPresident, CEO & Chairman | -8,52k | 1,45M | Automatic Disposition | 168,63 - 174,86 | 415,69k | -2,01% |
| 2026-01-09 | Dr. Martina FlammerChief Medical Officer | -1,89k | 351,34k | Automatic Disposition | 186,19 | 16,29k | -10,38% |
| 2026-01-06 | Mr. Roger AdsettCOO | -4,29k | 746,71k | Verkauf | 173,33 - 175,07 | 48,18k | -8,18% |
| 2026-01-06 | Ms. Sara M. BonsteinCFO | -4,64k | 808,73k | Verkauf | 173,33 - 175,07 | 8,76k | -34,64% |
| 2026-01-06 | Dr. Martina FlammerChief Medical Officer | -8,57k | 1,26M | Derivative Exercise and Sale | 26,43 - 175,01 | 18,18k | - |
| 2026-01-06 | Dr. Martina FlammerChief Medical Officer | -4,71k | 820,71k | Verkauf | 173,33 - 175,84 | 18,18k | -20,57% |
| 2026-01-08 | Dr. Martina FlammerChief Medical Officer | -3,25k | 566,23k | Automatic Disposition | 174,17 | 18,18k | -15,17% |
| 2026-01-06 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -3,16k | 549,49k | Verkauf | 173,33 - 175,07 | 57,04k | -5,25% |
| 2026-01-06 | Mr. William H. LewisPresident, CEO & Chairman | -9,68k | 1,68M | Verkauf | 173,33 - 175,07 | 424,21k | -2,23% |
| 2026-01-05 | Dr. Martina FlammerChief Medical Officer | -12,30k | 1,79M | Derivative Exercise and Sale | 19,74 - 175,73 | 20,93k | - |
| 2026-01-02 | Ms. S. Nicole SchaefferChief People Strategy Officer | -87,29k | 14,08M | Derivative Exercise and Sale | 13,91 - 177,78 | 41,75k | - |
| 2025-12-18 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,52M | Derivative Exercise and Sale | 17,16 - 171,20 | 405,43k | - |
| 2025-12-05 | Dr. Melvin SharokyIndependent Director | -20,00k | 4,10M | Verkauf | 205,01 | 264,74k | -7,02% |
| 2025-12-04 | Mr. William H. LewisPresident, CEO & Chairman | -10,70k | 1,93M | Derivative Exercise and Sale | 17,16 - 207,42 | 405,43k | - |
| 2025-12-01 | Dr. Martina FlammerChief Medical Officer | -8,90k | 1,61M | Derivative Exercise and Sale | 25,83 - 207,73 | 14,63k | - |
| 2025-11-24 | Ms. Elizabeth McKee AndersonIndependent Director | -5,00k | 1,02M | Verkauf | 204,58 | 53,67k | -8,52% |
| 2025-11-17 | Mr. Leo LeeIndependent Director | -75,00k | 14,69M | Verkauf | 193,51 - 197,40 | 49,62k | -60,18% |
| 2025-11-14 | Ms. Elizabeth McKee AndersonIndependent Director | -10,00k | 1,96M | Verkauf | 195,87 | 58,67k | -14,56% |
| 2025-11-12 | Ms. S. Nicole SchaefferChief People Strategy Officer | -30,00k | 5,03M | Derivative Exercise and Sale | 26,46 - 195,88 | 36,46k | - |
| 2025-11-11 | Dr. Martina FlammerChief Medical Officer | -31,23k | 5,36M | Derivative Exercise and Sale | 17,07 - 191,04 | 14,63k | - |
| 2025-11-06 | Mr. David R. BrennanLead Independent Director | -60,00k | 0,00 | Other Disposition | - | 121,88k | -32,99% |
| 2025-11-03 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -27,13k | 4,34M | Derivative Exercise and Sale | 23,75 - 187,97 | 54,90k | - |
| 2025-09-12 | Ms. S. Nicole SchaefferChief People Strategy Officer | -56,52k | 6,86M | Derivative Exercise and Sale | 23,75 - 145,67 | 36,46k | - |
| 2025-09-12 | Ms. S. Nicole SchaefferChief People Strategy Officer | -20,00k | 2,93M | Automatic Disposition | 145,67 - 147,46 | 36,46k | -35,42% |
| 2025-09-12 | Dr. Melvin SharokyIndependent Director | -10,00k | 1,45M | Verkauf | 145,39 | 289,61k | -3,34% |
| 2025-09-11 | Dr. Melvin SharokyIndependent Director | -2,16k | 0,00 | Other Disposition | - | 289,61k | -0,74% |
| 2025-09-04 | Ms. S. Nicole SchaefferChief People Strategy Officer | -23,30k | 0,00 | Other Disposition | - | 3,96k | -85,47% |
| 2025-09-02 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -12,78k | 1,44M | Derivative Exercise and Sale | 30,46 - 144,16 | 54,90k | - |
| 2025-09-02 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -11,49k | 1,66M | Automatic Disposition | 144,16 - 145,89 | 54,90k | -17,31% |
| 2025-09-02 | Dr. Martina FlammerChief Medical Officer | -186,65k | 22,57M | Derivative Exercise and Sale | 17,07 - 146,05 | 14,63k | - |
| 2025-08-20 | Dr. Melvin SharokyIndependent Director | -10,00k | 1,30M | Verkauf | 129,50 | 301,61k | -3,21% |
| 2025-08-19 | Mr. Roger AdsettCOO | -25,00k | 3,19M | Verkauf | 127,42 - 128,27 | 41,89k | -37,37% |
| 2025-08-18 | Mr. William H. LewisPresident, CEO & Chairman | -6,87k | 806,98k | Derivative Exercise and Sale | 10,85 - 129,47 | 405,43k | - |
| 2025-08-14 | Ms. S. Nicole SchaefferChief People Strategy Officer | -10,00k | 1,27M | Verkauf | 126,57 - 128,16 | 27,26k | -26,84% |
| 2025-08-12 | Dr. Melvin SharokyIndependent Director | -10,00k | 1,22M | Verkauf | 121,58 | 311,61k | -3,11% |
| 2025-08-13 | Dr. Melvin SharokyIndependent Director | -21,10k | 0,00 | Other Disposition | - | 311,61k | -6,34% |
| 2025-08-04 | Mr. William H. LewisPresident, CEO & Chairman | -6,83k | 675,90k | Derivative Exercise and Sale | 10,85 - 110,91 | 405,43k | - |
| 2025-08-04 | Dr. Martina FlammerChief Medical Officer | -8,72k | 782,26k | Derivative Exercise and Sale | 19,74 - 109,50 | 14,63k | - |
| 2025-07-21 | Ms. Sara M. BonsteinCFO | -47,89k | 3,45M | Derivative Exercise and Sale | 26,46 - 103,03 | 1,52k | - |
| 2025-07-21 | Ms. Sara M. BonsteinCFO | -10,51k | 1,08M | Automatic Disposition | 103,03 | 1,52k | -87,36% |
| 2025-07-15 | Mr. William H. LewisPresident, CEO & Chairman | -6,83k | 625,11k | Derivative Exercise and Sale | 10,85 - 103,32 | 405,43k | - |
| 2025-07-11 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -748,00 | 72,11k | Verkauf | 96,41 | 66,39k | -1,11% |
| 2025-07-15 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -933,00 | 95,64k | Automatic Disposition | 102,51 | 66,39k | -1,39% |
| 2025-07-07 | Ms. Sara M. BonsteinCFO | -47,89k | 3,37M | Derivative Exercise and Sale | 19,74 - 96,19 | 12,14k | - |
| 2025-07-07 | Ms. Sara M. BonsteinCFO | -9,88k | 949,97k | Automatic Disposition | 96,19 | 12,14k | -44,85% |
| 2025-07-01 | Mr. William H. LewisPresident, CEO & Chairman | -6,83k | 597,51k | Derivative Exercise and Sale | 10,85 - 99,61 | 405,43k | - |
| 2025-06-23 | Ms. Sara M. BonsteinCFO | -47,89k | 3,95M | Derivative Exercise and Sale | 18,95 - 101,71 | 21,55k | - |
| 2025-06-23 | Ms. Sara M. BonsteinCFO | -9,88k | 1,01M | Automatic Disposition | 101,71 - 102,15 | 21,55k | -31,42% |
| 2025-06-16 | Mr. William H. LewisPresident, CEO & Chairman | -129,81k | 11,62M | Derivative Exercise and Sale | 10,85 - 101,23 | 405,08k | - |
| 2025-06-16 | Mr. William H. LewisPresident, CEO & Chairman | -5,20k | 522,06k | Automatic Disposition | 98,51 - 101,39 | 405,08k | -1,27% |
| 2025-06-16 | Mr. Roger AdsettCOO | -10,69k | 1,06M | Automatic Disposition | 98,50 - 99,32 | 62,37k | -14,63% |
| 2025-06-10 | Dr. Martina FlammerChief Medical Officer | -45,16k | 3,10M | Derivative Exercise and Sale | 17,07 - 94,50 | 14,63k | - |
| 2025-06-10 | Ms. S. Nicole SchaefferChief People Strategy Officer | -108,30k | 8,24M | Derivative Exercise and Sale | 13,91 - 95,49 | 36,91k | - |
| 2025-06-11 | Ms. S. Nicole SchaefferChief People Strategy Officer | -29,17k | 2,79M | Automatic Disposition | 95,49 - 96,02 | 36,91k | -44,15% |
| 2025-06-10 | Ms. Sara M. BonsteinCFO | -47,89k | 3,39M | Derivative Exercise and Sale | 17,07 - 89,85 | 31,43k | - |
| 2025-06-10 | Ms. Sara M. BonsteinCFO | -9,88k | 894,37k | Automatic Disposition | 89,85 - 91,66 | 31,43k | -23,91% |
| 2025-06-05 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -1,88k | 138,11k | Automatic Disposition | 73,50 | 67,72k | -2,70% |
| 2025-06-03 | Mr. Michael Alexander SmithChief Legal Officer & Corporate Secretary | -1,45k | 103,53k | Verkauf | 71,50 | 69,60k | -2,04% |
| 2025-06-03 | Dr. Martina FlammerChief Medical Officer | -1,69k | 120,55k | Verkauf | 71,50 | 14,63k | -10,34% |
| 2025-06-03 | Mr. Roger AdsettCOO | -1,86k | 132,99k | Verkauf | 71,50 | 73,06k | -2,48% |
| 2025-06-03 | Ms. Sara M. BonsteinCFO | -1,58k | 112,90k | Verkauf | 71,50 | 41,30k | -3,68% |
| 2025-06-03 | Mr. David W. J. McGirrInsider | -6,25k | 451,54k | Automatic Disposition | 71,30 - 73,27 | 92,67k | -6,32% |
| 2025-06-03 | Ms. S. Nicole SchaefferChief People Strategy Officer | -1,64k | 117,40k | Verkauf | 71,50 | 114,40k | -1,42% |
| 2025-06-02 | Mr. William H. LewisPresident, CEO & Chairman | -6,83k | 412,94k | Derivative Exercise and Sale | 10,85 - 71,94 | 410,28k | - |
| 2025-06-03 | Mr. William H. LewisPresident, CEO & Chairman | -5,47k | 391,25k | Verkauf | 71,50 | 410,28k | -1,32% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
